The government is scrambling to reorient its Covid-19 vaccination plans after new evidence emerged on Sunday that AstraZeneca’s vaccine does not protect people against mild to moderate disease caused by the new variant detected in SA late last year. This vaccine is the cornerstone of the first phase of SA’s Covid-19 immunisation strategy.

"It is a temporary issue, until we figure out the next steps," health minister Zweli Mkhize said in a late night briefing. "The plan is to find out from scientists how to use it going forward."..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now